Exodus Point Capital Management, LP Neogenomics Inc Transaction History

Exodus Point Capital Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$6.45 - $12.07 $109,882 - $205,624	-17,036 Reduced 57.31%	12,691 $117,000
Q3 2022 Nov 10, 2022	SELL	$7.86 - $12.91 $59,775 - $98,180	-7,605 Reduced 20.37%	29,727 $256,000
Q2 2022 Aug 19, 2022	BUY	$7.06 - $13.97 $131,534 - $260,275	18,631 Added 99.63%	37,332 $304,000
Q1 2022 May 13, 2022	BUY	$12.15 - $35.28 $227,217 - $659,771	18,701 New	18,701 $227,000
Q4 2019 Feb 14, 2020	SELL	$18.96 - $29.84 $343,176 - $540,104	-18,100 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$19.12 - $26.24 $346,072 - $474,944	18,100 New	18,100 $346,000

295

125M

698K

120K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $2.06B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.